(Q36704838)

English

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey

scientific article published on 11 January 2007

Statements

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey (English)
11 January 2007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit